Fusion protein capable of improving the conversion efficiency of dammarenediol and its construction method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- TIANJIN UNIV
- Publication Date
- 2017-08-08
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biotechnology, in particular to a fusion protein capable of improving the conversion efficiency of dammarenediol and a construction method. Background technique
[0002] Ginsenoside is the main active ingredient of traditional Chinese medicine ginseng, which has the pharmacological effects of protecting cardiovascular, anti-fatigue, anti-aging and anti-cancer. Traditional ginseng cultivation, tissue culture and downstream plant tissue extraction have been difficult to meet the market demand for ginsenosides.
[0003] As a triterpenoid, the endogenous metabolic pathway of yeast can provide the precursor 2,3-oxysqualene for the synthesis of ginsenosides. Subsequent epoxidation, oxidation, and glycosyl addition are accomplished by dammarenediol synthase, protopanaxadiol synthase, and glycosyltransferase, respectively. The dammarenediol synthase gene was discovered in 2006. Tansakul et al. reported that PNA (DDBJ da...